NVIDIA 2011 Annual Report Download - page 95

Download and view the complete annual report

Please find page 95 of the 2011 NVIDIA annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 116

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116

NVIDIA CORPORATION AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
Note 19 - Quarterly Summary (Unaudited)
The following table sets forth our unaudited consolidated financial results, for the last eight fiscal quarters:
Fiscal Year 2011
Quarters Ended
January 30,
2011 (A) October 31,
2010 August 1,
2010 (B, C, D) May 2,
2010
(In thousands, except per share data)
Statement of Operations Data:
Revenue $ 886,376 $ 843,912 $ 811,208 $1,001,813
Cost of revenue $ 460,017 $ 451,850 $ 676,916 $ 545,436
Gross profit $ 426,359 $ 392,062 $ 134,292 $ 456,377
Net income (loss) $ 171,651 $ 84,862 $ (140,961) $ 137,594
Basic net income (loss) per share $ 0.29 $ 0.15 $ (0.25) $ 0.24
Diluted net income (loss) per share $ 0.29 $ 0.15 $ (0.25) $ 0.23
Fiscal Year 2010
Quarters Ended
January 31,
2010 October 25,
2009 (E) July 26, 2009
(F, G) April 26, 2009
(H)
(In thousands, except per share data)
Statement of Operations Data:
Revenue $ 982,488 $ 903,206 $ 776,520 $ 664,231
Cost of revenue $ 543,767 $ 511,423 $ 619,797 $ 474,535
Gross profit $ 438,721 $ 391,783 $ 156,723 $ 189,696
Net income (loss) $ 131,076 $ 107,577 $ (105,302) $ (201,338)
Basic net income (loss) per share $ 0.24 $ 0.20 $ (0.19) $ (0.37)
Diluted net income (loss) per share $ 0.23 $ 0.19 $ (0.19) $ (0.37)
(A) Included $57.0 million benefit, as a result of the Company and Intel entering into a new six-year cross licensing agreement. Both parties also agreed
to settle all outstanding legal disputes. Please refer to Note 13 of these Notes to Consolidated Financial Statements for details.
(B) Included $13.4 million benefit from an insurance provider as reimbursement for some claims against us towards the cost arising from a weak die/
packaging material set. Portions of the reimbursement are allocated to cost of revenue ($11.1 million) and legal expense ($2.3 million).
(C) Included $192.3 million warranty charge against cost of revenue arising from a weak die/packaging material set.
(D) Included $15.0 million charge related to a class action lawsuit settlement. Please refer to Note 13 of these Notes to Consolidated Financial
Statements for details.
(E) Included $25.1 million benefit from an insurance provider as reimbursement for some claims against us towards the cost arising from a weak die/
packaging material set. Portions of the reimbursement are allocated to cost of revenue ($24.1 million) and legal expense ($1.0 million).
(F) Included $164.5 million warranty charge against cost of revenue arising from a weak die/packaging material set.
(G) Included $45.4 million benefit from an insurance provider as reimbursement for some claims against us towards the cost arising from a weak die/
packaging material set. Portions of the reimbursement are allocated to cost of revenue ($44.5 million) and legal expense ($0.9 million).
(H) Included non-recurring charges of $140.2 million for the stock option purchase completed in March 2009 related to personnel associated with cost
of revenue, research and development and sales, general and administrative of $11.4 million, $90.5 million, and $38.3 million, respectively.
92